Sign inJoin free

Watch / Biotech

20 million reasons to smile; Dimerix moves one step closer to its dream

17 Aug 20213:24

20 million reasons to smile; Dimerix moves one step closer to its dream

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Dimerix (DXB) has raised $20m to fund its latest phase three trials. The placement will help fund the company's pathway from interim data to marketing approval. With such names as Andrew Chapman backing the deal, there is some interest clearly coming from even the big names in the industry. For more, we asked Dr Nina Webster, Dimerix CEO to explain the details.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy